Archives for November 24, 2005

← 2005

Catalyst creates new opportunities

By Kirsty Barnes

Degussa have discovered a catalyst that improves the efficiency of reductive carbonylation reactions and will provide greater access to new active pharmaceutical ingredients (APIs).

Report id's medico-ethical issues restrict gene therapy growth

By  Wai Lang Chu

Increasing knowledge about how to manage the risks of gene therapy is set to usher in a new era in disease therapies, with the prospect of developing treatments in treating rare, inherited, or life-threatening diseases very real.

Sun system strengthens drug counterfeit defense

By Kirsty Barnes

Sun Microsystems have strengthened the fight against drug counterfeiting by launching a unique RFID software package tailored to the specific needs of the pharmaceutical industry.

Cancer-related plant gene fosters new oncology drugs

By  Wai Lang Chu

Researchers have identified two proteins involved in the process that controls plant growth, which may help explain why human cells reject chemotherapy drugs and could form a basis for new oncology drugs.

Court rules Bio-Rad cease thermal cycler sales

By Wai Lang Chu

A US district court has denied a motion by Bio-Rad Laboratories to enforce an alleged settlement agreement with Applied Biosystems meaning the life science research product provider cannot continue selling its thermal cycler products.

Scientists discover motion protein promotes drug production

By  Wai Lang Chu

Researchers have shown how protein synthesis is targeted to certain regions of a cell, a process crucial for the cellular motility, which could form a basis for producing a drug that could force tumour cells to express this protein, preventing cancers...